Regulation of mda-7 gene expression during human melanoma differentiation

Oncogene

Volumn 19, Issue 10, 2000, Pages 1362-1368

  Madireddi, Malavi T ^a   Dent, Paul ^b   Fisher, Paul B ^a,c  

^a Columbia University ^*  (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

3' UTR; AUUUA; Human melanoma; Posttranscriptional gene regulation

Indexed keywords

BETA INTERFERON; COMPLEMENTARY DNA; LUCIFERASE; MELANOMA ANTIGEN; MESSENGER RNA; MEZEREIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MELANOMA CELL; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; SIMIAN VIRUS 40; TUMOR DIFFERENTIATION;

SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0034594998     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203424     Document Type: Article

References (42)

1. Aharon T and Schneider RJ. (1993). Mol. Cell. Biol., 13, 1971-1980.
2. Belasco JG and Higgins CF. (1988). Gene, 72, 15-23.
3. Elder PK, Schmidt LJ, Ono T and Getz MJ. (1984). Proc. Natl. Acad. Sci. USA, 81, 7476-7480.
4. Fisher PB, Prignoli DR, Hermo Jr H, Weinstein IB and Pestka S. (1985). Interferon Res., 5, 11-22.
5. Fontes AM, Ito J and Jacobs-Lorena M. (1999). Curr. Top. Dev. Biol., 44, 171-202.
6. Goeddel DV, Leung DW, Dull TJ, Gross M, Lawn RM, McCandliss R, Seeburg PH, Ullrich A, Yelverton E and Gray PW. (1981). Nature, 5, 20-26.
7. Gopalkrishnan RV, Christiansen KA, Goldstein NI, DePinho RA and Fisher PB. (1999). Nucl. Acids Res., 24, 4775-4782.
8. Huang F, Adelman J, Jiang H, Goldstein NI and Fisher PB. (1999a). Oncogene, 18, 3546-3552.
9. Huang F, Adelman J, Jiang H, Goldstein NI and Fisher PB. (1999b). Gene, 236, 125-131.
10. Huberman E and Callaham MF. (1979). Proc. Natl. Acad. Sci. USA, 76, 1293-1297.
11. Ishikawa M and Kerbel RS. (1989). Int. J. Cancer, 43, 134-139.
12. Jiang H, Waxman S and Fisher PB. (1993). Mol. Cell. Different., 1, 197-214.
13. Jiang H and Fisher PB. (1993). Mol. Cell. Different., 1, 285-299.
14. Jiang H, Lin J and Fisher PB. (1994). Mol. Cell. Different., 2, 221-239.
15. Jiang H, Lin JJ, Su Z-z, Goldstein NI and Fisher PB. (1995a). Oncogene, 11, 2477-2486.
16. Jiang H, Lin J, Su Z-z, Kerbel RS, Herlyn M, Weissman RB, Welch D and Fisher PB. (1995b). Oncogene, 10, 1855-1864.
17. Jiang H, Lin JJ, Su Z-z, Goldstein NI and Fisher PB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9160-9165.
18. Kang D-c, LaFrance R, Su Z-z and Fisher PB. (1998a). Proc. Natl. Acad. Sci. USA, 95, 13788-13793.
19. Kang D-c, Motwani M and Fisher PB. (1998b). Int. J. Oncol., 13, 1117-1126.
20. Krowczynska A, Yenofsky R and Brawerman G. (1985). J. Mol. Biol., 181, 231-239.
21. Linial M, Gunderson N and Groudine M. (1985). Science, 230, 1126-1132.
22. Madireddi MT, Su Z-z, Young CSH, Goldstein NI and Fisher PB. (2000). In: Cancer Gene Therapy: Past Achievements and Future Challenges, Habib N. (ed.). Plenum Publishing Company: New York, NY, in press.
23. Miller AD, Curran T and Verma IM. (1984). Cell, 36, 51-60.
24. Myer VE, Fan XC and Steitz JA. (1997). EMBO J., 16, 2130-2139.
25. Nedwin GE, Svedersky LP, Bringman TS, Palladino Jr MA and Goeddel DV. (1985). J. Imnnmol., 135, 2492-2497.
26. Patterson A and Harris AL. (1999). Drugs Aging. 14, 75-90.
27. Raj NB and Pitha PM. (1981). Proc. Natl. Acad. Sci. USA, 78, 7426-7430.
28. Rajagopalan LE and Malter JS. (1997). Prog. Nucleic Acid Res. Mol. Biol., 56, 257-286.
29. Ross J. (1996). Trends Genet., 12, 171-175.
30. Sachs L. (1980). Proc. Natl. Acad. Sci. USA, 77, 6152-6156.
31. Scott RE and Maercklein PB. (1985). Proc. Natl. Acad. Sci. USA, 82, 2995-2999.
32. Scott RE. (1997). Pharmacol. Ther., 73, 51-65.
33. Shaw G and Kamen R. (1986). Cell, 46, 659-667.
34. Shyu AB, Belasco JG and Greenberg ME. (1991). Genes Dev., 2, 221-231.
35. Spicher A, Guicherit OM, Duret L, Aslanian A, Sanjines EM, Denko NC, Giaccia AJ and Blau HM. (1998). Mol. Cell. Biol., 12, 7371-7382.
36. Su Z-z, Madireddi MT, Lin JJ, Young CSH, Kitada S, Reed JC, Goldstein NI and Fisher PB. (1998). Proc. Natl. Acad. Sci. USA, 95, 14400-14405.
37. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dimitrovsky E, Lander ES and Golub TR. (1999). Proc. Natl. Acad. Sci. USA, 96, 2907-2912.
38. van Straaten F, Muller R, Curran T, van Beveren C and Verma IM. (1983). Proc. Natl. Acad. Sci. USA, 80, 3183-3187.
39. Wada RK, Pai DS, Huang J, Yamashiro JM and Sidell N. (1997). Cancer Lett., 121, 181-188.
40. Waxman S, Rossi GB and Takaku F. (1991). The Status of Differentiation Therapy of Cancer, Waxman S, Rossi GB and Takaku F. (eds). Serono Symposia Pubs., Raven Press: New York.
41. Waxman S. (1995). Differentiation Therapy. Waxman S (ed.). Serono Symposium Publications: Rome, Italy.
42. Wong GG, Witek JS, Temple PA, Wilkens KM, Leary AC, Luxenberg DP, Jones SS, Brown EL, Kay RM, Orr EC, Shoemaker C, Golde DW, Kaufman RJ, Hewick RM, Wang EA and Clark SC. (1985). Science, 228, 810-815.